Position in ALLO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,437,177
+$1,473,880 QoQ
Shares Held
998,845
+42.1% QoQ
Ownership
0.289%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,425,095,484 across 521 Biotechnology names. ALLO ranks #206 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in ALLO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,437,177 | 998,845 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $963,297 | 703,138 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $1,610,963 | 1,299,166 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $688,131 | 608,969 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $3,435,524 | 2,353,101 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,127,006 | 998,596 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $4,820,280 | 1,721,530 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $5,025,717 | 2,156,962 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $9,976,875 | 2,231,964 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $5,353,717 | 1,667,826 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $4,380,043 | 1,381,718 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $6,617,239 | 1,331,437 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,848,482 | 981,475 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,349,508 | 850,479 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,653,000 | 616,019 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,964,818 | 1,137,265 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $15,381,694 | 1,688,441 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $18,889,536 | 1,266,055 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $27,319,764 | 1,063,026 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $29,456,782 | 1,129,478 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $3,303,371 | 93,580 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,651,815 | 342,782 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $7,557,647 | 200,415 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,015,536 | 47,070 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $920,075 | 47,329 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||